Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 11, 2011, Pages 1708-1713

  Chou, Joanne F ^a   Kernan, Nancy A ^a   Prockop, Susan ^a   Heller, Glenn ^a   Scaradavou, Andromachi ^a   Kobos, Rachel ^a   Knowles, Molly A ^a   Papadopoulos, Esperanza B ^a   Casson, Anne ^a   Copeland, Catherine ^a   Torok Castanza, Joanne ^a   Zakak, Nicole ^a   Ruggiero, Julianne ^a   Small, Trudy N ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Allogeneic; Immunization; Varicella

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CHICKENPOX; CHILD; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HUMAN; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; MALE; RETROSPECTIVE STUDY; SEROCONVERSION; T LYMPHOCYTE; VACCINATION;

ADOLESCENT; ADULT; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 80054852604     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.05.006     Document Type: Article

References (29)

1. Arbeter A.M. Clinical trials of varicella vaccine in healthy adolescents and adults. Infect Dis Clin North Am 1996, 10:609-615.
2. Tunbridge A.J., Breuer J., Jeffery K.J. British Infection Society. Chickenpox in adults. J Infect 2008, 57:95-102.
3. Marin M., Güris D., Chaves S.S., Schmid S., Seward J.F. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56:1-40.
4. Galea S.A., Sweet A., Beninger P., et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008, 197(Suppl 2):S165-S169.
5. Satori A.M. A review of the varicella vaccine in immunocompromised individuals. Int J Infect Dis 2004, 8:259-270.
6. Gershon A.A., Steinberg S.P., Gelb L., et al. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 1984, 252:355-362.
7. Khan S., Erlichman J., Rand E.B. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006, 10:78-82.
8. Weinberg A., Horslen S.P., Kaufman S.S., et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006, 6:565-568.
9. Armenian S.H., Han J.Y., Dunaway T.M., Church J.A. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Pediatr Infect Dis J 2006, 25:368-370.
10. Taweesith W., Puthanakit T., Kowitdamrong E., et al. The immunogenicity and safety of live attenuated varicella-aoster virus vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2011, 30:320-324.
11. Son M., Shapiro E.D., LaRussa P., et al. Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis 2010, 20:1806-1810.
12. Ljungman P., Engelhard D., de la Cámara R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005, 35:737-746.
13. Ljungman P., Cordonnier C., Einsele H., et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009, 44:521-526.
14. Sauerbrei A., Prager J., Hengst U., Zintl F., Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997, 20:381-383.
15. Small T.N., Kernan N.A., Prockop S., et al. Immunogenicity of the live attenuated varicella vaccine following allogeneic HCT. Blood 2009, 114:468a.
16. Kussmaul S.C., Horn B.N., Dvorak C.C., Abramovitz L., Cowan M.J., Weintrub P.S. Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant 2010, 45:1602-1606.
17. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
18. Sullivan K.M., Shulman H.M., Storb R., et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981, 57:267-276.
19. Small T.N., Papadopoulos E.B., Boulad F., et al. Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999, 93:467-480.
20. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for severe combined immunodeficiency disease with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutination and sheep red blood cells. Blood 1983, 61:341-348.
21. Casper J., Camitta B., Truitt R., et al. Unrelated bone marrow transplants for children with leukemia or myelodysplasia. Blood 1995, 85:2354-2363.
22. Jakubowski A.A., Small T.N., Young J.W., et al. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007, 110:4552-4559.
23. Kawasaki H., Takayama J., Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr 1996, 128:353-356.
24. Leung T.F., Chik K.W., Li C.K., et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000, 25:167-172.
25. Galil K., Lee B., Strine T., et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002, 347:1909-1915.
26. Chaves S.S., Gargiullo P., Zhang J.X., et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007, 356:1121-1129.
27. Gershon A., Katz S.L. Perspective on live varicella vaccine. J Infect Dis 2008, 197(Suppl 2):S242-S245.
28. Lawrence R., Gershon A., Holzman R., Steinberg S.P. The risk of zoster after varicella vaccination in children with leukemia. N Eng J Med 1988, 18:543-548.
29. Civen R., Chaves S.S., Jumaan A., et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009, 28:954-959.